Listed

China Pharma Holdings, Inc.: Form 10-K for the period ended Dec 31, 2013

Filed with the SEC on Mar 20, 2014 and accepted by EDGAR at Mar 20, 2014, 16:05 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2013-12-31. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue12 months2013-01-01 to 2013-12-31$32.8mus-gaap:Revenues
Cost of revenue12 months2013-01-01 to 2013-12-31$23.4mus-gaap:CostOfRevenue
Gross profit12 months2013-01-01 to 2013-12-31−$480.9kus-gaap:GrossProfit
Research and development12 months2013-01-01 to 2013-12-31$1.7mus-gaap:ResearchAndDevelopmentExpense
Operating income12 months2013-01-01 to 2013-12-31−$18.6mus-gaap:OperatingIncomeLoss
Interest expense12 months2013-01-01 to 2013-12-31−$348.7kus-gaap:InterestExpense
Income tax12 months2013-01-01 to 2013-12-31−$1.1mus-gaap:IncomeTaxExpenseBenefit
Net income12 months2013-01-01 to 2013-12-31−$20.0mus-gaap:NetIncomeLoss
Diluted EPS12 months2013-01-01 to 2013-12-31−$0.46us-gaap:EarningsPerShareDiluted
Basic EPS12 months2013-01-01 to 2013-12-31−$0.46us-gaap:EarningsPerShareBasic
Operating cash flow12 months2013-01-01 to 2013-12-31$8.6mus-gaap:NetCashProvidedByUsedInOperatingActivities
Capital expenditure12 months2013-01-01 to 2013-12-31−$18.8mus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Cash and equivalentsAt period end2013-12-31$6.0mus-gaap:Cash
Current assetsAt period end2013-12-31$84.0mus-gaap:AssetsCurrent
Total assetsAt period end2013-12-31$157.6mus-gaap:Assets
Current liabilitiesAt period end2013-12-31$12.0mus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2013-12-31$24.7mus-gaap:Liabilities
Shareholders' equityAt period end2013-12-31$132.9mus-gaap:StockholdersEquity
Shares outstandingAt period end2013-12-3143,579,557 sharesdei:EntityCommonStockSharesOutstanding

Source: SEC EDGAR, the filing index for accession 0001010549-14-000114. Last ingested by Listed: Nov 11, 2026, 00:23 ET. Listed shows no prices and gives no investment advice.